Article Information
PubMed
Published By
History
- Received January 5, 2009
- Revision received June 1, 2009
- Accepted June 8, 2009
- First published July 15, 2009.
- Version of record published July 15, 2009.
Copyright & Usage
Copyright © 2009 Society for Neuroscience 0270-6474/09/298901-13$15.00/0
Author Information
- Manabu Kokubo1,*,
- Masahiro Nishio1,*,
- Thomas J. Ribar1,
- Kristin A. Anderson1,
- Anne E. West2, and
- Anthony R. Means1
- Departments of 1Pharmacology and Cancer Biology and
- 2Neurobiology, Duke University Medical Center, Durham, North Carolina 27710
- Correspondence should be addressed to Dr. Anthony R. Means, Department of Pharmacology and Cancer Biology, Duke University Medical Center, P.O. Box 3813, Durham, NC 27710. means001{at}mc.duke.edu
Author contributions
-
↵*M.K. and M.N. contributed equally to this work.
Disclosures
- Received January 5, 2009.
- Revision received June 1, 2009.
- Accepted June 8, 2009.
-
This work was supported by National Institutes of Health Grant DK74701-35 (A.R.M.) and the National Alliance for Research on Schizophrenia and Depression Young Investigator Award (A.E.W.). We thank Rob Wechsler-Reya and Audra Lee for helpful discussions regarding the design and implementation of experiments involving cerebellar granule cells.
- Correspondence should be addressed to Dr. Anthony R. Means, Department of Pharmacology and Cancer Biology, Duke University Medical Center, P.O. Box 3813, Durham, NC 27710. means001{at}mc.duke.edu
Online Impact